Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats.

Bruijnzeel AW, Small E, Pasek TM, Yamada H.

Behav Brain Res. 2010 Jul 11;210(2):288-91. doi: 10.1016/j.bbr.2010.02.043. Epub 2010 Mar 1.

2.

A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal.

Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL.

Alcohol Clin Exp Res. 2009 Sep;33(9):1582-8. doi: 10.1111/j.1530-0277.2009.00986.x. Epub 2009 May 26.

3.

Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Licata SC, Rowlett JK.

Pharmacol Biochem Behav. 2008 Jul;90(1):74-89. doi: 10.1016/j.pbb.2008.01.001. Epub 2008 Jan 12. Review.

4.

Treatment options for sleep disturbances during alcohol recovery.

Arnedt JT, Conroy DA, Brower KJ.

J Addict Dis. 2007;26(4):41-54. Review.

5.

Long-term use of benzodiazepines in participants with comorbid anxiety and alcohol use disorders.

Mueller TI, Pagano ME, Rodriguez BF, Bruce SE, Stout RL, Keller MB.

Alcohol Clin Exp Res. 2005 Aug;29(8):1411-8.

6.

Single versus multiple drug focus in substance abuse clinical trials research.

Rounsaville BJ, Petry NM, Carroll KM.

Drug Alcohol Depend. 2003 May 21;70(2):117-25. Review.

7.

Alprazolam use and dependence. A retrospective analysis of 30 cases of withdrawal.

Dickinson B, Rush PA, Radcliffe AB.

West J Med. 1990 May;152(5):604-8.

Supplemental Content

Support Center